Q3 revenue: +12.1% (+9.4% on a like-for-like basis)
9-month revenue: +8.9% (+7.3% on a like-for-like basis)
Full-year growth guidance close to +10% in H2 confirmed
06 Nov 2025
EQUASENS (EQS) - Q3 : Recovery confirmed / BUY - TARGET : €76.7 / +108%
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
EQUASENS (EQS) - Q3 : Recovery confirmed / BUY - TARGET : €76.7 / +108%
Q3 revenue: +12.1% (+9.4% on a like-for-like basis)
9-month revenue: +8.9% (+7.3% on a like-for-like basis)
Full-year growth guidance close to +10% in H2 confirmed